Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser:: A pilot study

被引:78
作者
Nouri, K [1 ]
Bowes, L [1 ]
Chartier, T [1 ]
Romagosa, R [1 ]
Spencer, J [1 ]
机构
[1] Univ Miami, Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL USA
关键词
D O I
10.1046/j.1524-4725.1999.08248.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. Melasma is very difficult to treat and often refractory to treatment with topical creams and pigmented-lesion lasers. OBJECTIVE. Pulsed CO2 laser alone is compared with the combination of pulsed CO2 laser followed by Q-switched alexandrite laser in the treatment of dermal-type melasma. This combination is proposed to be effective by first destroying the abnormal melanocytes with the pulsed CO2 laser and then selectively eliminating the dermal melanin with the alexandrite laser. METHODS. Four patients were randomly chosen for each treat- ment arm. There were multiple follow-up visits for examination by an objective blinded investigator. RESULTS. All patients in the combination laser group showed complete resolution, and two patients in the CO2 laser only group had peripheral hyperpigmentation in the long-term follow-up evaluation. CONCLUSTION. These laser therapies are safe, as there was no scarring and no infection. The combination laser therapy was highly effective in removing the hyperpigmentation and all patients in this group showed complete resolution without any peripheral hyperpigmentation.
引用
收藏
页码:494 / 497
页数:4
相关论文
共 13 条
[1]   THE TREATMENT OF MELASMA - 20-PERCENT AZELAIC ACID VERSUS 4-PERCENT HYDROQUINONE CREAM [J].
BALINA, LM ;
GRAUPE, K .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (12) :893-895
[2]   AZELAIC ACID - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN ACNE AND HYPERPIGMENTARY SKIN DISORDERS [J].
FITTON, A ;
GOA, KL .
DRUGS, 1991, 41 (05) :780-798
[3]   BENIGN PIGMENTED LESIONS OF THE SKIN - TREATMENT WITH THE Q-SWITCHED RUBY-LASER [J].
GOLDBERG, DJ .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1993, 19 (04) :376-379
[4]   510-NM PIGMENTED LESION DYE-LASER - ITS CHARACTERISTICS AND CLINICAL USES [J].
GREKIN, RC ;
SHELTON, RM ;
GEISSE, JK ;
FRIEDEN, I .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1993, 19 (04) :380-387
[5]   TOPICAL TRETINOIN (RETINOIC ACID) IMPROVES MELASMA - A VEHICLE-CONTROLLED, CLINICAL-TRIAL [J].
GRIFFITHS, CEM ;
FINKEL, LJ ;
DITRE, CM ;
HAMILTON, TA ;
ELLIS, CN ;
VOORHEES, JJ .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (04) :415-421
[6]   MELASMA - ETIOLOGIC AND THERAPEUTIC CONSIDERATIONS [J].
GRIMES, PE .
ARCHIVES OF DERMATOLOGY, 1995, 131 (12) :1453-1457
[7]  
KLIGMAN AM, 1975, ARCH DERMATOL, V111, P40
[8]   USEFULNESS OF RETINOIC ACID IN THE TREATMENT OF MELASMA [J].
PATHAK, MA ;
FITZPATRICK, TB ;
KRAUS, EW .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (04) :894-899
[9]   A HYDROQUINONE SOLUTION IN THE TREATMENT OF MELASMA [J].
SANCHEZ, JL ;
VAZQUEZ, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1982, 21 (01) :55-58
[10]   MELASMA - A CLINICAL, LIGHT MICROSCOPIC, ULTRASTRUCTURAL, AND IMMUNOFLUORESCENCE STUDY [J].
SANCHEZ, NP ;
PATHAK, MA ;
SATO, S ;
FITZPATRICK, TB ;
SANCHEZ, JL ;
MIHM, MC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 4 (06) :698-710